Tagged Content

Tags > Medication Updates
Year: Medication:  Abilify (aripiprazole) Addyi Antipsychotics Aripiprazole Aristada Belsomra Brintellix Buprenorphine and naloxone Probuphine Clozapine Chantix and Zyban Cymbalta Daytrana Diazepam Effexor Farxiga Fentanyl and Opioids Geodon Hysingla ER Ingrezza Lunesta Methylphenidate Naloxone/Evzio Naltrexone Olanzapine Olanzapine/Zyprexa Opana ER Opioids Opioids and Benzodiazepines Rexulti Strattera Tanzeum Targiniq ER Tramadol Treatment for Alcohol Use Disorder Vraylar Vynase Ziprasidone Zolpidem Zyprexa General Resources:   DEA Pharmacists' Manual FDA Medication Updates NIMH Mental Health Medications Guide         2017 FDA requests market removal of oxymorphone hydrochloride for risks related to abuse The FDA is concerned that Opana ER (oxymorphone hydrochloride), an opioid pain medication, has risks that now outweigh its benefits. First generic Strattera approved by FDA for ADHD treatment The FDA has approved the first generic versions of Strattera (atomoxetine) to treat attention-deficit/hyperactivity disorder (ADHD) in pediatric and adult patients. FDA approves Ingrezza, the first drug to treat tardive dyskinesia Ingrezza (valbenazine) treats tardive dyskinesia, a neurological disorder characterized by repetitive involuntary movements.



View all tags
View RSS XML
The American Psychiatric Nurses Association is accredited with distinction as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.

Announcing the 2017 APNA Annual Awards Recipients
Nine psychiatric-mental health nurses have been named the recipients of this year's APNA Annual Awards in recognition of their achievements.  |  View

Registration Opens for APNA 31st Annual Conference
The APNA 31st Annual Conference offers invaluable networking opportunities, 100+ continuing education contact hours, and a full spectrum of psychiatric-mental health nursing topics.  |  View

Free CE of the Month: July 2017
Four free sessions are available to APNA members through July 31st.  |  View

PCSS-MAT Waiver Training Available Now
Free PCSS-MAT waiver training is now available for nurses and physician assistants.  |  View

National Patient Safety Goal Related to Suicide: Call for Comments
The Joint Commission is seeking comments on its proposed revisions to the NPSG Related to Suicide for hospitals.  |  View

Take Action: #StandforMentalHealth
Share the new APNA position paper on proactive health care policies to ease the burden of mental illness and substance use disorders.  |  View

Tobacco Dependence Resources
Updated expert-vetted online resources from the Tobacco Dependence Branch of the APNA Addictions Council.  |  View

New Education to Address Opioid Use Crisis
The no cost educational sessions were designed to support nurses in all fields as they address the opioid use epidemic. |  View

New Resources on Violence Prevention
New toolkit and position paper to support psychiatric-mental health nurses in their violence prevention efforts. |  View